Drug Shortage Report for ACETAZOLAMIDE FOR INJECTION, USP

Last updated on 2024-10-01 History
Report ID 188809
Drug Identification Number 02358328
Brand name ACETAZOLAMIDE FOR INJECTION, USP
Common or Proper name ACETAZOLAMIDE FOR INJECTION, USP
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) ACETAZOLAMIDE
Strength(s) 500MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 1 VIAL
ATC code S01EC
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Demand increase for the drug.
Anticipated start date 2024-06-01
Actual start date
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2024-10-01
Company comments The resupply date is TBD.
Health Canada comments
Tier 3 Status No
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v19 2024-10-01 French Compare
v18 2024-10-01 English Compare
v17 2024-08-08 French Compare
v16 2024-08-08 English Compare
v15 2024-06-02 English Compare
v14 2024-04-30 French Compare
v13 2024-04-30 English Compare
v12 2024-04-30 French Compare
v11 2024-04-30 English Compare
v10 2024-01-25 French Compare
v9 2024-01-25 English Compare
v8 2024-01-25 English Compare
v7 2023-07-01 English Compare
v6 2023-06-19 French Compare
v5 2023-06-19 English Compare
v4 2023-05-02 French Compare
v3 2023-05-02 English Compare
v2 2023-04-05 French Compare
v1 2023-04-05 English Compare

Showing 1 to 19 of 19